患有慢性阻塞性肺病和心房的患者的处方模式
Kuang-Ming Liao1, Pei-Jun Chen2, Chung-Yu Chen3,4,5
1Department of Internal Medicine, Chi Mei Medical Center, Chiali, Taiwan.
Open medicine (Warsaw, Poland)
|December 4, 2023
概括
患有慢性阻塞性肺病 (COPD) 和心房 (AF) 的患者最常被处方阿司匹林. 非维生素K对抗剂口服抗凝剂 (NOAC) 的使用在这个人群中很低,比华法林更少.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有慢性阻塞性肺病 (COPD) 的患者面临患上心房动 (AF) 的风险较高.
- 在COPD患者中有效管理AF需要仔细考虑抗血栓治疗,以减轻中风风险.
研究的目的:
- 为了研究诊断为COPD和AF的患者的抗血栓药物处方模式.
- 为了比较非维生素K对抗剂口服抗凝剂 (NOACs) 与华法林在这个特定患者队列中的使用情况.
主要方法:
- 使用台湾医疗保健数据进行了一项回顾性队列研究.
- 包括40至90岁的COPD确诊患者和至少一个AF诊断的患者.
- 分析了AF诊断后30天内服用抗血栓药物的处方数据.
主要成果:
- 总共有6,582名患有同时出现的慢性肺炎和肌痛性肺炎的患者被分析,平均年龄为75岁.
- 阿司匹林是最常见的抗血栓剂 (31%),其次是华法林 (8.22%).
- 在AF诊断后30天内,NOAC的处方率显著较低,低于华法林使用.
结论:
- 目前台湾对COPD和AF患者的抗血栓药物处方做法大多倾向于阿司匹林和华法林.
- 在这个高风险人群中,NOACs的使用量显著不足,这表明在遵循指南的护理中存在潜在的差距.
- 需要进行进一步的研究,以了解NOAC采用的障碍,并优化COPD患者中风预防策略.
相关概念视频
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
174
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
174
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
65
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
65
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
21
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
21